Investor Relations

Our specialty pharmaceuticals, branded generics and consumer products play a role in helping millions of people live healthier lives and providing treatment to those affected by debilitating diseases. We remain committed to improving the health and well-being of people everywhere, profitably growing our businesses, and bringing value to our shareholders.

In response to recent events, Valeant has developed an online archive of rebuttals to many of the allegations that have been made against the company. You can find these rebuttals here.

Copyright © 2012 Valeant. All rights reserved.